US Stock MarketDetailed Quotes
MLAB Mesa Laboratories
- 132.080
- +0.680+0.52%
Close Dec 20 16:00 ET
- 132.080
- 0.0000.00%
Post 20:01 ET
717.38MMarket Cap-2.90P/E (TTM)
136.270High129.750Low141.81KVolume129.750Open131.400Pre Close18.74MTurnover2.68%Turnover RatioLossP/E (Static)5.43MShares140.80952wk High4.44P/B698.50MFloat Cap83.46652wk Low0.64Dividend TTM5.29MShs Float328.839Historical High0.48%Div YieldTTM4.96%Amplitude2.654Historical Low132.162Avg Price1Lot Size
Mesa Laboratories Key Stats
Quarterly+Annual
YOY
| (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.78%57.83M | 14.86%58.17M | -1.32%216.19M | 5.96%58.9M | -1.50%53.47M | -9.50%53.17M | 0.38%50.65M | 18.85%219.08M | -5.58%55.59M | -0.75%54.29M |
| Operating revenue | 8.78%57.83M | 14.86%58.17M | -1.32%216.19M | 5.96%58.9M | -1.50%53.47M | -9.50%53.17M | 0.38%50.65M | 18.85%219.08M | -5.58%55.59M | -0.75%54.29M |
| Cost of revenue | 6.28%22.38M | 7.50%20.92M | -2.87%82.94M | -0.19%22.35M | -6.74%20.07M | -5.84%21.06M | 1.83%19.46M | 13.48%85.39M | -5.79%22.39M | -17.44%21.52M |
| Gross profit | 10.42%35.46M | 19.45%37.25M | -0.33%133.25M | 10.11%36.56M | 1.94%33.4M | -11.75%32.11M | -0.50%31.18M | 22.55%133.69M | -5.44%33.2M | 14.45%32.77M |
| Operating expense | -0.69%31.95M | -0.56%31.67M | 0.32%130.79M | 1.91%33.31M | 13.98%33.47M | -0.69%32.17M | -11.38%31.85M | 24.89%130.37M | -7.21%32.68M | -5.70%29.36M |
| Selling and administrative expenses | 0.50%27.31M | -0.38%26.93M | 1.46%111.49M | 1.54%28.11M | 18.76%29.18M | -0.82%27.18M | -10.58%27.04M | 23.99%109.88M | -7.87%27.68M | -5.42%24.57M |
| -Selling and marketing expense | 2.06%9.85M | 12.70%10.12M | 3.17%38.63M | 4.94%10.26M | 15.41%9.74M | 4.89%9.65M | -10.45%8.98M | 32.25%37.44M | -0.73%9.78M | -5.82%8.44M |
| -General and administrative expense | -0.35%17.46M | -6.88%16.82M | 0.58%72.87M | -0.32%17.84M | 20.52%19.44M | -3.71%17.53M | -10.65%18.06M | 20.12%72.44M | -11.35%17.9M | -5.22%16.13M |
| Research and development costs | -7.19%4.63M | -1.58%4.74M | -5.81%19.3M | 3.96%5.2M | -10.49%4.29M | 0.08%4.99M | -15.60%4.81M | 29.95%20.49M | -3.38%5M | -7.11%4.8M |
| Operating profit | 5,946.67%3.51M | 940.36%5.58M | -25.96%2.46M | 528.43%3.25M | -101.97%-67K | -101.50%-60K | 85.55%-664K | -29.39%3.32M | 570.00%517K | 235.43%3.4M |
| Net non-operating interest income expense | -233.48%-3.02M | -171.18%-2.84M | -19.43%-5.7M | -36.81%-1.89M | -59.72%-1.86M | 25.45%-905K | -3.35%-1.05M | -22.78%-4.77M | -11.47%-1.38M | -14.15%-1.16M |
| Non-operating interest expense | 233.48%3.02M | 171.18%2.84M | 19.43%5.7M | 36.81%1.89M | 59.72%1.86M | -25.45%905K | 3.35%1.05M | 22.78%4.77M | 11.47%1.38M | 14.15%1.16M |
| Other net income (expense) | 1,022.78%3.32M | 50.58%1.17M | -25,774.74%-272.41M | -47,317.24%-276.69M | 1,294.14%3.87M | -159.70%-360K | 295.41%775K | -61.52%1.06M | -54.99%586K | -127.25%-324K |
| Special income (charges) | --0 | --3.2M | ---274.53M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --274.53M | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| -Less:Other special charges | ---- | ---3.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 1,022.78%3.32M | -361.94%-2.03M | 100.19%2.12M | -468.60%-2.16M | 1,294.14%3.87M | -159.70%-360K | 295.41%775K | -61.52%1.06M | -54.99%586K | -127.25%-324K |
| Income before tax | 387.70%3.81M | 516.76%3.91M | -70,760.67%-275.65M | -99,297.83%-275.33M | 1.57%1.95M | -139.15%-1.33M | 82.69%-937K | -110.88%-389K | -502.17%-277K | 181.85%1.92M |
| Income tax | 504.21%384K | 233.25%517K | -1,522.59%-21.4M | -2,236.60%-20.75M | -111.60%-170K | -104.57%-95K | 90.24%-388K | -177.45%-1.32M | -151.09%-888K | 621.35%1.47M |
| Net income | 378.70%3.43M | 717.12%3.39M | -27,438.28%-254.25M | -41,766.61%-254.58M | 369.18%2.12M | -194.18%-1.23M | 61.82%-549K | -50.29%930K | 134.25%611K | 121.89%451K |
| Net income continuous Operations | 378.70%3.43M | 717.12%3.39M | -27,438.28%-254.25M | -41,766.61%-254.58M | 369.18%2.12M | -194.18%-1.23M | 61.82%-549K | -50.29%930K | 134.25%611K | 121.89%451K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 378.70%3.43M | 717.12%3.39M | -27,438.28%-254.25M | -41,766.61%-254.58M | 369.18%2.12M | -194.18%-1.23M | 61.82%-549K | -50.29%930K | 134.25%611K | 121.89%451K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 378.70%3.43M | 717.12%3.39M | -27,438.28%-254.25M | -41,766.61%-254.58M | 369.18%2.12M | -194.18%-1.23M | 61.82%-549K | -50.29%930K | 134.25%611K | 121.89%451K |
| Basic earnings per share | 373.91%0.63 | 730.00%0.63 | -27,864.71%-47.2 | -43,009.09%-47.2 | 387.50%0.39 | -192.00%-0.23 | 62.96%-0.1 | -52.78%0.17 | 132.35%0.11 | 120.51%0.08 |
| Diluted earnings per share | 373.91%0.63 | 720.00%0.62 | -27,864.71%-47.2 | -43,009.09%-47.2 | 387.50%0.39 | -195.83%-0.23 | 62.96%-0.1 | -51.43%0.17 | 132.35%0.11 | 120.51%0.08 |
| Dividend per share | 0.00%0.16 | 0.00%0.16 | 0.00%0.64 | 0.00%0.16 | 0.00%0.16 | 0.00%0.16 | 0.00%0.16 | 0.00%0.64 | 0.00%0.16 | 0.00%0.16 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data